Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis. [electronic resource]
Producer: 19961024Description: 39-48 p. digitalISSN:- 0957-5235
- Animals
- Antithrombins -- therapeutic use
- Arthropod Proteins
- Blood Coagulation Tests
- Coronary Thrombosis -- drug therapy
- Disease Models, Animal
- Dogs
- Factor Xa Inhibitors
- Female
- Hirudin Therapy
- Intercellular Signaling Peptides and Proteins
- Male
- Microscopy, Electron, Scanning
- Peptides -- therapeutic use
- Serine Proteinase Inhibitors -- therapeutic use
- Sodium Chloride -- pharmacology
- Thrombolytic Therapy
- Ticks
- Vascular Patency -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.